Relationship Between Maternal Bone Biomarkers and Fetal Adiposity Through Normal Pregnancy.

Purpose: To examine the association of maternal bone markers [sclerostin, soluble receptor activator of nuclear factor-κB ligand (sRANKL), osteocalcin, 25-hydroxyvitamin D3] with fetal intra-abdominal and subcutaneous adipose tissue deposition and birthweight during normal pregnancy.

Methods: One hundred pregnant women (aged 30.4 ± 5.